Our study summarized the published literatures and revealed a positive prognostic effect of SF3B1 mutation and an adverse prognostic effect of SRSF2/U2AF1/ZRSR2 mutations in patients with MDS. Here, SF3B1 is linked to myelodysplastic syndrome.